NOVAVAX INC (NVAX) - historický vývoj ceny NOVAVAX INC po letech, minima, maxima, průměr. Měna USD
Akcie Novavax, Inc. (NVAX) - grafy, minima, maxima, data. Vývoj kurzu NVAX v letech 1995 až 2026.
Kurzy NOVAVAX INC v jednotlivých letech v USD
| Rok | začátek | závěr | minimum | maximum | průměr |
| 2026 |
7.1300 | 9.3000 |
7.1300 | 11.190 | 8.9034 |
| 2025 |
8.5700 | 6.7200 |
5.4300 | 10.820 | 7.5481 |
| 2024 |
5.0300 | 8.0400 |
3.7600 | 20.970 | 9.3652 |
| 2023 |
9.7900 | 4.8000 |
4.8000 | 12.480 | 7.7879 |
| 2022 |
142.90 | 10.280 |
8.8600 | 142.90 | 50.294 |
| 2021 |
112.98 | 143.07 |
112.98 | 319.93 | 193.65 |
| 2020 |
4.4900 | 111.51 |
3.9300 | 178.51 | 69.301 |
| 2019 |
39.400 | 3.9800 |
3.6900 | 46.800 | 12.101 |
| 2018 |
26.000 | 36.800 |
23.400 | 49.600 | 35.176 |
| 2017 |
25.400 | 24.800 |
14.680 | 32.600 | 23.459 |
| 2016 |
157.60 | 25.200 |
23.600 | 166.80 | 95.152 |
| 2015 |
115.20 | 167.80 |
114.80 | 282.80 | 179.27 |
| 2014 |
104.20 | 118.60 |
73.800 | 133.00 | 98.442 |
| 2013 |
39.400 | 102.40 |
35.000 | 103.20 | 52.376 |
| 2012 |
27.600 | 37.800 |
23.200 | 47.800 | 33.055 |
| 2011 |
51.400 | 25.200 |
23.600 | 59.200 | 39.455 |
| 2010 |
56.200 | 48.600 |
40.200 | 60.400 | 47.077 |
| 2009 |
40.400 | 53.200 |
11.200 | 133.00 | 55.974 |
| 2008 |
65.200 | 37.800 |
27.600 | 70.600 | 51.606 |
| 2007 |
77.400 | 66.600 |
51.800 | 90.000 | 67.264 |
| 2006 |
77.600 | 82.000 |
56.800 | 166.20 | 93.837 |
| 2005 |
64.800 | 77.000 |
14.800 | 110.60 | 42.305 |
| 2004 |
120.20 | 65.200 |
58.600 | 138.40 | 92.441 |
| 2003 |
56.000 | 120.00 |
52.780 | 164.42 | 102.64 |
| 2002 |
272.40 | 52.000 |
37.200 | 272.40 | 120.59 |
| 2001 |
168.20 | 282.00 |
138.80 | 300.60 | 213.73 |
| 2000 |
115.00 | 170.00 |
95.000 | 231.20 | 152.43 |
| 1999 |
40.000 | 112.40 |
38.800 | 118.80 | 77.305 |
| 1998 |
101.20 | 38.800 |
27.600 | 116.20 | 66.519 |
| 1997 |
67.600 | 100.00 |
60.000 | 115.00 | 87.758 |
| 1996 |
80.000 | 68.800 |
60.000 | 162.40 | 98.865 |
| 1995 |
77.600 | 75.000 |
66.200 | 82.400 | 72.500 |
Graf NOVAVAX INC v USD
Zprávy novavax inc
Zobrazit sloupec